Dietary and lifestyle factors in relation to plasma insulin-like growth factor I in a general population sample

European Journal of Cancer Prevention

Volumn 12, Issue 3, 2003, Pages 229-234

  Baibas, N ^a   Bamia, C ^a   Vassilopoulou, E ^a   Sdrolias, J ^b   Trichopoulou, A ^a   Trichopoulos, D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Biomed International Diagnostic Center   (Greece)

Author keywords

Diet; Dietary lipids; Ethanol; IGF I; IGFBP 3; Smoking

Indexed keywords

ALCOHOL; CARBOHYDRATE; HORMONE; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; PROTEIN; SATURATED FATTY ACID; SOMATOMEDIN C;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY HEIGHT; BODY MASS; CANCER INCIDENCE; CANCER RISK; CARBOHYDRATE INTAKE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIET; DISEASE ASSOCIATION; ENERGY EXPENDITURE; FATTY ACID BLOOD LEVEL; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; LIFESTYLE; MALE; NORMAL HUMAN; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SMOKING; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; DIET; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; FOOD HABITS; GREECE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIFE STYLE; LIPIDS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SEX FACTORS; SMOKING; STATISTICS;

EID: 0038516837     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200306000-00010     Document Type: Article

References (64)

1. Ainsworth B, Haskell WL, Leon AS (1993). Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 2:71-80.
2. Andersson SO, Wolk A, Bergstrom R, et al. (1997). Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 89:385-389.
3. Baxter RC (1988). Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 67:265-272.
4. Benbassat CA, Maki KC, Unterman TG (1997). Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. J Clin Endocrinol Metab 82:1484-1491.
5. Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS (1998). Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 9:570-573.
6. Chan JM, Stampfer MJ, Giovanucci E, et al. (1998). Plasma insulin growth factor-I and prostate cancer risk: a prospective study. Science 219:563-566.
7. Cohen P (1998). Serum insulin-like growth factor-I levels and prostate cancer risk-interpreting the evidence. J Natl Cancer Inst 90: 876-879.
8. Cruickshank JK, Heald AH, Anderson S, et al. (2001). Epidemiology of the insulin-like growth factor in three ethnic groups. Am J Epidemiol 154:504-513.
9. de Herder WW, van der Lely AJ, Lamberts SW (1997). Colorectal cancer screening in acromegaly. Still many unresolved questions. Clin Endocrinol (Oxford) 47:644-646.
10. Dricu A, Kanter L, Wang M, et al. (1999). Expression of the insulin-like growth factor I receptor (IGF-IR) in breast cancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-I pathway. Glycobiology 22:21-29.
11. Giovannucci E, Rimm EB, Stampfer MJ, et al. (1995). Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6:557-563.
12. Gnardellis C, Trichopoulou A, Katsouyianni K, et al. (1995). Reproducibility and validity of an extensive semi-quantitative Food Frequency Questionnaire among Greek school teachers. Epidemiology 6:74-77.
13. Goodman-Gruen D, Barrett-Connor E (1996). Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: the Rancho Bernardo Study. J Clin Endocrinol Metab 81:4268-4271.
14. Goodman-Gruen D, Barrett-Connor E (1997). Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 145:970-976.
15. Hall K, Hilding A, Thoren M (1999). Determinants of circulating insulin-like growth factor-I. J Endocrinol Invest 22(Suppl 5):48-57.
16. Hankinson SE, Willett WC, Colditz GA, et al. (1998). Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396.
17. Harris TB, Kiel D, Roubenoff R, et al. (1997). Association of insulin-like growth factor-I with body composition, weight history, and past health behaviors in the very old: the Frammingham Heart Study. J Am Geriatr Soc 45:133-139.
18. Hebert PR, Ajani U, Cook NR, et al. (1997). Adult height and incidence of cancer in male physicians (United States). Cancer Causes Control 8:591-597.
19. Holmes MD, Pollak MN, Hankinson SE (2002). Lifestyte correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11:862-867.
20. Janssen JA, Stolk RP, Pols HA, et al. (1998). Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol 18:277-282.
21. Jones JI, Clemmons DR (1995). Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34.
22. Kaaks R, Lucanova A (2001). Energy balance and cancer: the role. Proc Nutr Soc 60:1-16.
23. Kaklamani VG, Linos A, Kaklamani E, et al. (1999a). Age sex, and smoking are predictors of circulating insulin-like growth factor I and insulin-like growth factor protein 3. J Clin Oncol 17:813-817.
24. Kaklamani VG, Linos A, Kaklamani E, et al. (1999b). Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor I and insulin-like growth factor binding-protein 3 concentrations in healthy adults. J Clin Oncol 17:3291-3298.
25. Katsouyianni K, Rimm EB, Gnardellis C, et al. (1997). Reproducibility and relative validity of an extensive semi-quantitative Food Frequency Questionnaire using dietary records and chemical markers among Greek school teachers. Int J Epidemiol. 26 (Suppl 1):S118-S127.
26. Kelley KM, Oh Y, Gargosky SE, et al. (1996). Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28:619-637.
27. Koziris LP, Hickson RC, Chatterton RT, et al. (1999). Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J Appl Physiol 86:1436-1442.
28. Lagiou P, Ye W, Wedren S, et al. (2001). Incidence of ovarian cancer among alcoholic women: a cohort study in Sweden. Int J Cancer 91:264-266.
29. Landin-Whilhemsen K, Wilhelmsen L, Lappas G, et al. (1994). Serum insulin-like growth factor I in a random population sample of men and women: relation to age smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxford) 41:351-357.
30. Lipworth L, Martinez ME, Angell J, Hsieh CC, Trichopoulos D (1997). Olive oil and human cancer: an assessment of the evidence. Prev Med 26:181-190.
31. Lucanova A, Toniolo P, Akhmedkhanov A, et al. (2001). A cross-sectional study of IGF-I determinants in women. Eur J Cancer Prev 10:443-437.
32. Ma J, Pollak MN, Giovannucci E, et al. (1999). Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620-625.
33. MacDonald RG, Schaffer BS, Kang IJ, et al. (1999). Growth inhibition and differentiation of the human colon carcinoma cell line, Caco-2, by constitutive expression of insulin-like growth factor binding protein-3. J Gastroenterol Hepatol 14:72-78.
34. Manousos O, Souglakos J, Bosetti C, et al. (1999). IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer 83:15-17.
35. Mantzoros CS, Tzonou A, Signorello LB, et al. (1997). Insulin like growth factor I in relation to prostate cancer and benign prostate hyperplasia. Br J Cancer 76:1115-1118.
36. Martinez ME, Giovannucci E, Spiegelman D, et al. (1997). Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst 89:948-955.
37. Mathur SP, Mathur RS, Young RC (2000). Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer. Am J Reprod Immunol 44:222-230.
38. Mucci LA, Tamini R, Lagiou P, et al. (2001). Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? Br J Urol 87(9):814-820.
39. Oh Y, Muller HL, Lamson G, Rosenfeld RG (1993). Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 268:14964-14971.
40. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997). Cancer in Five Continents, Vol VII. IARC Scientific Publications No. 143. Lyon, France.
41. Perks CM, Bowen S, Gill ZP, Newcomb PV, Holly JM (1999). Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells. J Cell Biochem 75:652-664.
42. Petridou E, Dessypris N, Spanos E, et al. (1999). Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia. Int J Cancer 80:494-496.
43. Pietrzkowski Z, Mulholland G, Gomella L, et al. (1993). Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor-I. Cancer Res 53:1102-1106.
44. Pollak M, Beamer W, Zhang JC (1998-99). Insulin-like growth factors and prostate cancer. Cancer Metastasis Rev 17:383-390.
45. Rajah R, Valentinis B, Cohen P (1997). Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta 1 on programmed cell death through a p53-and IGF-independent mechanism. J Biol Chem 272:12181-12188.
46. Riboli E, Kaaks R (1997). The EPIC Project: rationale and study design. Int J Epidemiol 26(Suppl 1):1S6-1S14.
47. Roelen CA, de Vries WR, Kopperschaar HP, et al. (1997). Plasma insulin-like growth factor-I and high affinity growth hormone-binding protein levels increase after two weeks of strenuous physical training. Int J Sports Med 18:238-241.
48. Ron E, Gridley G, Hrubec Z, et al. (1991). Acromegaly and gastrointestinal cancer. Cancer 68:1673-1677.
49. Signorello LB, Kuper H, Lagiou P, et al. (2000). Lifestyle factors and insulin-like growth factor I levels among elderly men. Eur J Cancer Prev 9:173-178.
50. Stata Corp. (1999). Intercooled Stata 6.0 for Windows 98/95/NT. 702 University Drive, East College Station, Texas 77840, USA.
51. Tennant MK, Thrasher JB, Twomey PA, et al. (1996a). Protein and messenger ribonucleic acid (mRNA) for the type-I insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrinol Metab 81:3774-3782.
52. Tennant MK, Thrasher JB, Twomey PA, Birnbaum RS, Plymate SR (1996b). Insulin like growth factor binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. J Clin Endocrinol Metab 81:411-420.
53. Tretli S (1989). Height and weight in relation to breast cancer morbidity and mortality: a prospective study of 570,000 women in Norway. Int J Cancer 44:23-30.
54. Trichopoulou A (1992.) Composition of Greek Foods and Dishes (in Greek and English). Athens: Athens School of Public Health.
55. Trichopoulou A, Bamia C, Kalapothaki V, et al. (2003). Dehydroepiandrosterone relations to dietary and lifestyle variables in a general population sample. Annals Nutrition Metabolism (in press).
56. Trichopoulou A, Gnardellis C, Lagiou P, Benetou V, Trichopoulos D (2000). Body mass index in relation to energy intake and expenditure among adults in Greece. Epidemiology 11:333-336.
57. Underwood LE, van Wyk JJ (1998). Normal and abberant growth. In: Wilson JD, Foster DW (editors): Williams Textbook of Endocrinology. Philadelphia: W.B. Saunders: pp. 1079-1138.
58. Voskuil DW, Bas Bueno de Mesquita H, Kaaks R, et al. (2001). Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1-3 in premenopausal women: physical activity and anthropometry (Netherlands). Cancer Causes Control 12:951-958.
59. Willett WC (1998.) Nutritional Epidemiology. New York: Oxford University Press.
60. Williams AC, Collard TJ, Perks CM, et al. (2000). Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Cancer Res 60:22-27.
61. Wolk A, Mantzoros CS, Andersson SO, et al. (1998). Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 90:911-915.
62. Yee D, Paik S, Lebovic GS, et al. (1989). Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol 3:509-517.
63. Yu H, Rohan T (2000). Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 91:151-156.
64. Yu H, Spitz MR, Mistry J, et al. (1999). Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 91:151-156.